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CONCURRENT DERMATOMYOSITIS AND METASTATIC BREAST 
CARCINOMA: 
CASE REPORT 
*DoNALD R. KELLOGG, M.D. AND **ROBERT W . TALLEY, M.D. 
Simultaneous occurrence of neoplasia and dermatomyositis was first reported by 
Stertz in 1916\ He described the case of a 55-year-old male with dermatomyositis, 
who subsequently was found to have carcinoma of the stomach. In 1935, the rela-
tionship again was mentioned by Bezecny^ who reported three cases of dermatomyositis 
associated with tumor. 
Various, and occasionally conflicting, statements have been made regarding the 
incidence of coexisting dermatomyositis and malignant tumors. In a review of 590 
cases of dermatomyositis reported in world literature, Williams^ found 92 patients 
(over 15%) with concurrent malignant tumors. 
Dermatomyositis occurs most frequently in the younger population, particularly 
in the second and third decades." When dermatomyositis exists in middle-aged and 
elderly people, the incidence of concurrent neoplasia increases with each decade. 
Thus, Shy' found cancer and polymyopathy associated in 5% of patients under 50 
and 39% of those over 50. The youngest patient reported was an 11-year-old girl with 
a chromophobe adenoma'. In patients over 50, the frequency of polymyositis with 
malignancy was 71% in males as compared to 24% in females. Pearson' later pointed 
out that dermatomyositis, unassociated with malignancy, affected females twice as often 
as males; but the syndrome of dual disorders was observed nearly three times more 
often in men than in women. 
Occurrence of dermatomyositis with malignant tumors has been described with 
various primary neoplasms, the most common being breast, stomach, and lung malig-
nancies. Carcinomas of most sites of the body have been reported in the combined 
occurrence, with the exception of thyroid and testicular neoplasms". 
*Formerly an Intern, Division of Oncology 
Present address: Surgical Resident, University Hospital, Loma Linda, Califomia 
** Chief, Division of Oncology 
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CASE REPORT 
A 44-year-old-Caucasian female underwent a right radical mastectomy and 
bilateral salpingo-oophorectomy in October 1960, because of mass in her right breast, 
which proved to be adenocarcinoma. Right axillary node recurrence three years later 
was treated with radiation therapy. 
In October 1965 she developed nausea, vomiting, and generalized weakness, for 
which no definite cause was found. Radiological survey of the skeleton did not demon-
strate metastatic diseases. Peripheral blood smear contained 18% segmented neutrophils, 
15% lymphocytes, 10% monocytes, and 27% eosinophils. 
In December 1965 the patient developed an erythematous rash on her malar 
eminences, hands, neck, thighs, as well as marked proximal thigh weakness. 
On January 18, 1966, physical findings in this acutely ill patient were these: 
a temperature of 101 °F; a scaling, erythematous eruption across the malar eminences; 
erythematous, bullous lesions on the chest and lateral aspect of thighs; a heliotrope 
appearance of the para-ungual skin of hands; a 2 x 2 cm. mass in the medial superior 
portion of the left breast, and a 1 x 2 cm. lymph node in the left axilla. Weakness of 
pelvic girdle and quadriceps muscle was present, and severe. 
Laboratory findings were as follows: hemoglobin 8.3 g.%; WBC 3,100 cells cm.\ 
with a normal differential count; normal urinalysis sedimentation rate of 51 mm./hr.; 
SGOT 43 units; latex fixation test was weakly reactive; normal alkaline phosphatase; 
BSP negative; urinary creatinine-creatine ratio was 2:1; C reactive protein was 
positive to a dilution of 1:8. At this time, skeletal roentgenograms revealed destructive 
lesions in the skull, ribs, and pelvis. 
The patient's symptom complex was felt to represent adenocarcinoma of the 
breast with associated dermatomyositis. A skin and muscle biopsy of the left thigh 
revealed pathological changes in both skin and muscle consistent with the diagnosis 
of dermatomyositis. 
A left simple mastectomy was performed, and confirmed the diagnosis of adeno-
carcinoma; but it could not be determined whether this lesion was primary or metastatic. 
The day following the procedure, the patient showed a marked increase in the 
inflammatory appearance of her cutaneous lesions, with new bullous formation. The 
skin lesions and muscle weakness responded rapidly and favorably to high doses of 
corticosteroids. 
In an attempt to palliate the extensive metastatic breast cancer, a hypophysectomy 
was performed two weeks later. No effect was noted on the rapid progress of the 
patient's metastatic disease. Moderately severe diabetes insipidus developed necessitating 
large doses of intramuscular pitressin for control. Corticosteroids continued to be 
required because of the dermatomyositis. 
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Six weeks later, the patient developed the clinical picture of obstructive jaundice, 
and at laparotomy a metastatic tumor mass was found in the porta hepatis. A cholecystos-
tomy was unsuccessful in decreasing the severe jaundice, and she expired on the 
fifteenth postoperative day. Autopsy confirmed the presence of extensive metastatic 
carcinoma. 
DISCUSSION 
Muscular weakness is a common symptom of dermatomyositis, occurring in 
95% of patients. Even though the skin manifestations may precede myositis, diagnosis 
cannot be established with certainty, without both skin and muscle findings. As shown 
in this case, usually the first symptoms are weakness in the proximal muscle groups. 
Although muscular atrophy may be present, the degree of weakness is disproportion-
ately greater than the atrophy. 
The most helpful laboratory tests are those which reflect tissue destruction — 
such as serum aldolase, creatine phosphatase, transaminases, and lactic dehydrogenase.' 
The urinary creatinine-creatine ratio usually is less than 10:1. Eosinophiha, as 
described in this patient, has been reported by Dostrovsky." 
Skin changes in the disease vary, ranging from a local or diffuse erythema to a 
scaling eczematoid or exfoliative dermatitis. When no skin lesions are present, the 
disorder is called polymyositis. 
Frequently, polymyositis has been confused with the muscular dystrophies.' 
Dowben et a/.'° maintain that the clinical features most helpful in the differential 
diagnosis are the presence of cutaneous lesions, muscular pain or tenderness, and 
dysphagia. Diagnostically, subjective decrease in muscle weakness and improvement 
in appearance of skin lesions, with corticosteroid therapy, are felt to be important 
in dermatomyositis. Although these features do not always occur in dermatomyositis 
associated with malignancy, they may be present, as in the case being reported. 
Dermatomyositis associated with malignancy is exceedingly rare in young patients. 
The etiology of dermatomyositis remains obscure. Diverse factors, such as infection, 
endocrine disorders, allergy, and aberrations of Vitamin E metabolism have been 
suggested as possibly etiologic in the pathogenesis of the disorder. Many investigators 
now feel that the syndrome represents an autoimmune process. 
Because of the high incidence of coexisting malignancy and dermatomyositis, it 
is apparent the relationship is more than coincidental. In 1935, Bezecny^ reported 
improvement in dermatomyositis, following primary therapy of the malignancy. Sheard 
and Knoepfler" reported a patient with metastatic breast cancer and dermatomyositis. 
After hypophysectomy the patient experienced a regression of the breast cancer, with 
subsequent improvement in dermatomyositis. Unfortunately, such was the the case 
in our patient. Curtis'^ in 1952 suggested that tumors might be antigenic. Williams 
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in 1959^ in a literature review further affirmed this hypothesis. He found evidence 
of improvement of the dermatomyositis in nine patients, after primary surgical or 
radiological therapy of the associated tumor. 
In 1959 Grace and Dao" intradermally injected extracts of removed tumor and 
normal tissue into a patient with concurrent dermatomyositis and adenocarcinoma of 
the breast. A marked reaction occurred at the injection site of the tumor tissue extract 
while only a minimal reaction occurred at the site of the normal tissue. They also 
demonstrated, by passive transfer studies, that the reaction was specific for the tumor 
tissue extract. 
The tumor antigen itself is thought to be a polysaccharide". Thus, it is possible 
that muscle and skin may be the "shock organs" in an autoimmune process. 
In the present case, postoperative flare of the patient's skin lesions perhaps 
can best be explained by the sudden release of large quantities of antigenic material, 
caused by manipulation of the tumor during surgery. 
SUMMARY 
The case of a 44-year-old woman with concurrent dermatomyositis and metastatic 
breast carcinoma is presented. Incidence, factors to be considered in diagnosis, and 
a possible explanation of the relationship of dermatomyositis and malignancy are 
discussed. 
Because of the high incidence of malignancy in older patients with dermatomyo-
sitis, all patients over 50 with dermatomyositis or polymyopathy should be suspected 
of having an associated malignancy. The theoretical explanation for the increased 
incidence of dermatomyositis with malignancy is an autoimmune process, with the 
antigens derived from the neoplastic tissue. 
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